RERHX | STITX | RERHX / STITX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 30 years | - |
Gain YTD | 2.028 | 0.711 | 285% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 127B | 363M | 34,986% |
Annual Yield % from dividends | 1.71 | 0.20 | 843% |
Returns for 1 year | 4.11 | -25.23 | -16% |
Returns for 3 years | -8.28 | -29.75 | 28% |
Returns for 5 years | 1.16 | -36.25 | -3% |
Returns for 10 years | N/A | -27.80 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ANTGX | 8.12 | 0.08 | +1.00% |
American Century Non-US Intrs Val G | |||
TGVYX | 54.82 | 0.52 | +0.96% |
Touchstone Growth Opportunities Y | |||
HHHCX | 16.67 | 0.07 | +0.42% |
Hartford Schroders Emerging Mkts Eq C | |||
APHWX | 10.45 | N/A | N/A |
Artisan Value Income Institutional | |||
FBTCX | 20.20 | -0.10 | -0.49% |
Fidelity Advisor Biotechnology C |